ImmunoGen (IMGN) Q2 2022 Earnings Call Transcript
With me today are Mark Enyedy, our president and CEO; Anna Berkenblit, our chief medical officer; Kristen Harrington-Smith, our chief commercial officer; and Susan Altschuller, our CFO. During today's call, we will review recent accomplishments for the business, our Q2 financial results, and highlight upcoming anticipated events.